Kangmei Pharma | 600518 - Ebitda

株価
1.65
毎日の変更
-0.04 -2.37%
毎月
-6.78%
毎年
-15.82%
Q2 予測
1.67




Ebitda 変化する 日付
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Genomma Lab Internacional MXN 912.6M 59.06M 2026-03
Hypermarcas BRL 729.21M 26.99M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Jiangsu Hengrui CNY 2.3B 678.46M 2025-12
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Moderna USD -790M 582M 2025-12
Organon & Co USD 415M 32M 2026-03
Revvity USD 272.91M 24M 2026-03
Sh Fosun Pharma CNY 1.57B 128.23M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1.05B 46.4M 2026-03
WuXi AppTec CNY 5.64B 3.31B 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03